Agilent Technologies and National Cancer Centre Singapore Enter into Research Collaboration Agreement

Agilent Technologies signed a research collaboration agreement with the National Cancer Centre Singapore (NCCS) to accelerate a step forward in the field of translational cancer research, particularly in the context of Asian-prevalent cancers.

Over the next two years, this partnership aims to expedite progress in understanding the genomic landscape of cancers that are prevalent in Asian populations. This agreement seeks to fast-track advancements in unravelling the genomic characteristics of cancer types that have a high prevalence among Asian populations.

Agilent's automated NGS library preparation platform at Singapore's Cancer Discovery Hub (CDH) aims to simplify the analysis of multiple genes and complex genetic abnormalities within genomic DNA, ensuring consistent and reproducible results. 

This research focuses on improving the understanding of tumour genomes and harnessing this information to enhance patient care. Ultimately, the platform's deployment has the potential to revolutionise clinical trials, diagnostics, and treatment decisions in oncology.

The goal of this collaboration is to translate these findings into practical applications for patient care. This includes improving the accuracy and effectiveness of clinical trials and diagnostics in the field of oncology, as well as enhancing the decision-making process for treatment strategies. Moreover, this partnership will accelerate the development of next-generation diagnostic tools, ultimately reshaping the landscape of patient care in cancer.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!